H E Webb. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Chronic DiseaseComa/therapyDactinomycin/therapeutic useDaunorubicin/therapeutic useDexamethasone/administration & dosageEncephalomyelitis/complicationsEncephalomyelitis/drug therapyEncephalomyelitis/therapyFever/therapyHeadache/drug therapyHumansIdoxuridine/adverse effectsIdoxuridine/therapeutic useLeukopenia/chemically inducedMeningitis, Viral/drug therapyMeningitis, Viral/therapyMental Disorders/drug therapyMental Disorders/etiologyPain/drug therapyParalysis/therapyRespiratory Insufficiency/therapyRifampin/therapeutic useVomiting/drug therapy
Substances: See more » DactinomycinDexamethasoneIdoxuridineRifampinDaunorubicin
Year: 1969 PMID: 5356552 PMCID: PMC1630009 DOI: 10.1136/bmj.4.5683.603
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447